BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhuang X, Liu C, Zhan S, Tian Z, Li N, Mao R, Zeng Z, Chen M. Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Front Pediatr 2021;9:626232. [PMID: 33604319 DOI: 10.3389/fped.2021.626232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun Q, Du M, Kang Y, Zhu MJ. Prebiotic effects of goji berry in protection against inflammatory bowel disease. Crit Rev Food Sci Nutr 2022;:1-25. [PMID: 34991393 DOI: 10.1080/10408398.2021.2015680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ventin-Holmberg R, Höyhtyä M, Saqib S, Korpela K, Nikkonen A, Salonen A, de Vos WM, Kolho KL. The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α. Sci Rep 2022;12:6654. [PMID: 35459927 DOI: 10.1038/s41598-022-10548-7] [Reference Citation Analysis]
3 Tian Z, Zhuang X, Zhuo S, Zhu Y, Hu S, Zhao M, Tang C, Zhang Z, Li X, Ma R, Zeng Z, Feng R, Chen M. Dietary inflammatory potential mediated gut microbiota and metabolite alterations in Crohn's disease: A fire-new perspective. Clinical Nutrition 2022. [DOI: 10.1016/j.clnu.2022.04.014] [Reference Citation Analysis]
4 Eindor-Abarbanel A, Healey GR, Jacobson K. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood. Int J Mol Sci 2021;22:12506. [PMID: 34830388 DOI: 10.3390/ijms222212506] [Reference Citation Analysis]
5 Zhang B, Liu K, Yang H, Jin Z, Ding Q, Zhao L. Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples. Front Cell Infect Microbiol 2022;12:855075. [DOI: 10.3389/fcimb.2022.855075] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang WH, Jin ZY, Yang ZH, Zhang JY, Ma XH, Guan J, Sun BL, Chen X. Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis by Downregulating Pro-inflammatory Cytokines in Mucosa and Serum. Front Microbiol 2022;13:818111. [PMID: 35444617 DOI: 10.3389/fmicb.2022.818111] [Reference Citation Analysis]
7 Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. Int J Mol Sci 2022;23:3464. [PMID: 35408838 DOI: 10.3390/ijms23073464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
8 Sarbagili Shabat C, Scaldaferri F, Zittan E, Hirsch A, Mentella MC, Musca T, Cohen NA, Ron Y, Fliss Isakov N, Pfeffer J, Yaakov M, Fanali C, Turchini L, Masucci L, Quaranta G, Kolonimos N, Godneva A, Weinberger A, Kopylov U, Levine A, Maharshak N. Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial. J Crohns Colitis 2021:jjab165. [PMID: 34514495 DOI: 10.1093/ecco-jcc/jjab165] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kathrani A, Yen S, Swann JR, Hall EJ. The effect of a hydrolyzed protein diet on the fecal microbiota in cats with chronic enteropathy. Sci Rep 2022;12:2746. [PMID: 35177696 DOI: 10.1038/s41598-022-06576-y] [Reference Citation Analysis]